# Short Bowel Syndrome and Teduglutide Versus Placebo

> **NCT02099084** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 8 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Teduglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02099084
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099084, "Short Bowel Syndrome and Teduglutide Versus Placebo". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02099084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*